Evidence map›Paper›PMID 40525176›Full record

ArticleAnnals of thoracic surgery short reports2025

Robotic One Anesthetic Diagnosis and Treatment: A Novel Program for Lung Cancer Care.

Benjamin A Palleiko, Mark W Maxfield, Rahul N Sood, Shi Bai, Andrew Fischer, Karl Uy, Kevin M Dickson, Edward Kim, Isabel Emmerick, Feiran Lou

Abstract read
In one paragraph

Article in Annals of thoracic surgery short reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Benjamin A PalleikoDivision of Thoracic Surgery, UMass Chan Medical School, Worcester, Massachusetts.
Mark W MaxfieldDivision of Thoracic Surgery, UMass Chan Medical School, Worcester, Massachusetts.
Rahul N SoodDivision of Interventional Pulmonology, UMass Chan Medical School, Worcester, Massachusetts.
Shi BaiDivision of Pathology, UMass Chan Medical School, Worcester, Massachusetts.
Andrew FischerDivision of Pathology, UMass Chan Medical School, Worcester, Massachusetts.
Karl UyDivision of Thoracic Surgery, UMass Chan Medical School, Worcester, Massachusetts.
Kevin M DicksonDivision of Thoracic Surgery, UMass Chan Medical School, Worcester, Massachusetts.
Edward KimDivision of Thoracic Surgery, UMass Chan Medical School, Worcester, Massachusetts.
Isabel EmmerickDivision of Thoracic Surgery, UMass Chan Medical School, Worcester, Massachusetts.
Feiran LouDivision of Thoracic Surgery, UMass Chan Medical School, Worcester, Massachusetts.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Early diagnosis and treatment of lung cancer can improve patient outcomes. To reduce the delay between diagnosis and treatment, we initiated a Robotic One Anesthetic Diagnosis and Treatment (ROADAT) program for lung nodules that combined robotic navigational bronchoscopy, liquid rapid on-site evaluation (ROSE), and surgical resection in the same setting. Methods: A retrospective review was conducted of patients who underwent the ROADAT procedure from December 1, 2021, through January 31, 2024. These patients were compared with sequential controls from the same time window, who would have been ROADAT candidates but underwent diagnosis and treatment using a standard lung nodule workup. Results: There were 36 patients in the ROADAT group and 35 controls. Of the 36 ROADAT patients, 31 (86%) underwent lung resections. When final pathology was available, ROSE was concordant in 91% (29 of 32) of cases. Compared with robotic lobectomies alone, ROADAT procedures that resulted in lobectomies added 73 minutes ( Conclusions: The ROADAT procedure reduced time from nodule detection to surgical resection compared with the standard approach. Liquid-based ROSE had high concordance with final pathology. Total operative time, direct costs, and total costs were lower for the ROADAT procedure.

Identifiers

PMID40525176
PMCPMC12167552

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.